Relentless A Look Inside Mold-Related Illness | Ariana Thacker, Moldco
Nov 11, 2025
Ariana Thacker, cofounder and CEO of Moldco, shares her journey from personal mold-related illness to developing a virtual clinic for effective treatment. She discusses the overlooked nature of mold illnesses, highlighting genetic susceptibility and the chronic impacts of exposure. Ariana explains her three-step clinical protocol and the importance of treating the majority first. Additionally, she addresses how mold can affect mental health, metabolism, and the need for greater public awareness, all while sharing insights on scaling healthcare solutions in the mold space.
AI Snips
Chapters
Transcript
Episode notes
Founder’s Personal Mold Journey
- Ariana got sick from mold in an HVAC while renting a Miami condo and discovered the cause after months of normal test results.
- An inspector found high Aspergillus and Penicillium in the HVAC, and she moved out after six and a half months of exposure.
Genetic Susceptibility Explains Variable Risk
- Genetic susceptibility maps to HLA haplotypes on chromosome 6 and may make ~1 in 4 Americans prone to chronic reactions.
- Susceptible individuals struggle to bind and clear biotoxins, prolonging inflammation after exposure.
A Simple Three-Step Treatment Pathway
- Follow a three-step clinical sequence: detox with a binder, nasal biofilm treatment, then VIP peptide for repair.
- Use evidence-based, programmatic protocols tailored to patient subtypes for scalable virtual care.